Eloxx Pharmaceuticals Inc.
ELOX | NASDAQ
$13.45
+$0.27 (+2.05%)
At close: Oct 30, 2026, 4:00 PM ET
$13.90
+$0.45 (+3.35%)
After-hours:
Oct 30, 2026, 7:30 PM ET
+2.05%
(1D)No price chart data available for 1D timeframe.
Rating
30.2
-3.0 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #791/1028 (Top 77%)
Key Statistics
Market Data
Market Cap $46.22M
1D Range
12.99 13.85
52W Range
10.95 20.98
Valuation (TTM)
PE -8.85
PB 1.00
EV/EBITDA 1.93
Valuation (NTM)
Forward PE 0.54
Forward PEG 0.09
Price Target $36.67
Cash Flow
FCF Yield -22.2%
SBC Adj. FCF Yield -22.5%
SBC Impact -1.4%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y 0.0% |
50.0%
Dil EPS 3Y | 5Y 95.8% |
51.2%
FCF 3Y | 5Y 63.5% |
27.8%
Returns
ROA -13.0%
ROE -42.5%
ROIC -17.8%
Financial Health
Net Cash
$61.96M
Current Ratio 3.74
Interest Coverage -222.84
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical firm that specializes in developing therapeutic solutions through ribosome modulation. Its primary objective is to address rare and ultra-ra...
Sector Healthcare
Industry Biotechnology
Employees 10
IPO Date Jun 9, 2026
Website www.eloxxpharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$38.00
Upside
+182.53%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove ELOX